MYLI
TEVA icon

Meiji Yasuda Life Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,000
Closed -$129K – 336
2021
Q2 		$129K Buy
+13,000
New +$138K ﹤0.01% 318
2021
Q1 		– Sell
-11,300
Closed -$109K – 335
2020
Q4 		$109K Buy
+11,300
New +$108K ﹤0.01% 302
2017
Q2 		– Sell
-6,400
Closed -$205K – 334
2017
Q1 		$205K Sell
6,400
-1,200
-16% -$41K 0.03% 307
2016
Q4 		$276K Buy
+7,600
New +$303K 0.05% 275

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Meiji Yasuda Life Insurance's TEVA Position: Q3 2021 in Review

Meiji Yasuda Life Insurance sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 13,000 shares — an estimated $129K sold.

Meiji Yasuda Life Insurance first reported a position in TEVA in Q4 2016 and held it in 4 quarters. The position peaked at $276K in Q4 2016. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Meiji Yasuda Life Insurance reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 13,000 Teva Pharmaceuticals shares in Q3 2021, an estimated $129K.
  • Meiji Yasuda Life Insurance first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 4 quarters.
  • Meiji Yasuda Life Insurance's Teva Pharmaceuticals position peaked at $276K in Q4 2016.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Meiji Yasuda Life Insurance's 13F filing for Q3 2021, filed 12 Nov 2021.